Cover Image
Market Research Report

Asia Pacific Vascular Guidewires Market Forecast 2019-2027

Published by Inkwood Research Product code 904358
Published Content info 81 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia Pacific Vascular Guidewires Market Forecast 2019-2027
Published: August 7, 2019 Content info: 81 Pages
Description

KEY FINDINGS

The Asia Pacific vascular guidewires market is expected to evolve around CAGR of 5.97% during the estimated period of 2019-2027. The densely populated region, with the presence of developing economies like India and China, provides tremendous opportunities for the vascular guidewires market.

MARKET INSIGHTS

The Asia Pacific market is mainly influenced by the trends of countries, namely South Korea, China, Australia, India, Japan, and Rest of Asia Pacific region that includes other countries from the Pacific Rim. The adoption of urbanization and sedentary lifestyles lead to rising cases of cardiovascular disorders. Therefore, the vascular guidewires market is expected to witness mounting growth in the region owing to rising disposable income and high adoption rates of vascular intervention procedures. As vascular guidewires are a vital part of vascular intervention treatment, the surging adoption will drive the vascular guidewires market. Further, with the technological developments in elements and coating types of guidewires, the market is providing lucrative prospects for the manufacturers.

COMPETITIVE INSIGHTS

B Braun Melsungen AG, Koninklijke Philips N.V., Boston Scientific Corporation, Abbott, Terumo, Biotronik Se & Co. KG, Olympus Corporation, Merit Medical Systems, Becton Dickinson and Company, and Medtronic, among others, are few companies operating in the vascular guidewires market. The leading companies launch new products along with initiatives like business expansion to hold major market share. Also, as the market comprises vendors ranging from big, medium to small, the market is highly competitive.

Table of Contents
Product Code: 26222

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. CORONARY GUIDEWIRES ARE THE MAJORLY USED APPLICATION
    • 3.2.2. HYDROPHOBIC COATING IS THE FASTEST GROWING COATED TYPE
    • 3.2.3. HOSPITALS ARE THE HIGHEST REVENUE GENERATING END USERS

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. RISE IN PREVALENCE OF CHRONIC DISEASES
    • 4.2.2. INCREASING DEMAND FOR MI PROCEDURES
    • 4.2.3. AWARENESS AMONG PATIENTS ABOUT TREATMENT OPTIONS
    • 4.2.4. PREVAILING HIGH UNMET MEDICAL NEEDS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. RISKS ASSOCIATED WITH THE USE OF GUIDEWIRES
    • 4.3.2. UNFAVORABLE PREFERENCE FOR DRUGS
    • 4.3.3. ISSUE IN LOST GUIDEWIRE RETRIEVAL
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. TECHNOLOGICAL ADVANCEMENTS
    • 4.4.2. SURGE IN THE ADOPTION OF VASCULAR PROCEDURES
  • 4.5. MARKET CHALLENGES
    • 4.5.1. COMPLEXITIES ASSOCIATED IN THE MANUFACTURING OF VASCULAR GUIDEWIRES
    • 4.5.2. PRICING COUPLED WITH PAUCITY OF PRODUCT DIFFERENTIATION

5. MARKET BY APPLICATION

  • 5.1. CORONARY GUIDEWIRES
  • 5.2. PERIPHERAL GUIDEWIRES
  • 5.3. UROLOGICAL GUIDEWIRES
  • 5.4. NEUROVASCULAR GUIDEWIRES

6. MARKET BY COATING TYPE

  • 6.1. COATED
  • 6.2. NON-COATED

7. MARKET BY END USER

  • 7.1. HOSPITALS
  • 7.2. AMBULATORY SURGICAL CENTERS

8. KEY ANALYTICS

  • 8.1. PORTER'S FIVE FORCES MODEL
    • 8.1.1. THREAT OF NEW ENTRANTS
    • 8.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 8.1.3. BARGAINING POWER OF BUYER
    • 8.1.4. BARGAINING POWER OF SUPPLIER
    • 8.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 8.2. VALUE CHAIN ANALYSIS
  • 8.3. REGULATORY FRAMEWORK
  • 8.4. SUPPLY CHAIN ANALYSIS
  • 8.5. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS

  • 9.1. ASIA PACIFIC
    • 9.1.1. JAPAN
    • 9.1.2. CHINA
    • 9.1.3. INDIA
    • 9.1.4. AUSTRALIA
    • 9.1.5. SOUTH KOREA
    • 9.1.6. REST OF APAC

10. COMPETITIVE LANDSCAPE

  • 10.1. MARKET SHARE ANALYSIS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ABBOTT
    • 10.2.2. B BRAUN MELSUNGEN AG
    • 10.2.3. BECTON DICKINSON AND COMPANY
    • 10.2.4. BIOTRONIK SE & CO. KG
    • 10.2.5. BOSTON SCIENTIFIC CORPORATION
    • 10.2.6. CARDINAL HEALTH INC.
    • 10.2.7. COOK MEDICAL LLC
    • 10.2.8. EDWARD LIFESCIENCES
    • 10.2.9. GALTNEEDLETECH
    • 10.2.10. KONINKLIJKE PHILIPS N.V.
    • 10.2.11. MEDTRONIC
    • 10.2.12. MERIT MEDICAL SYSTEMS
    • 10.2.13. OLYMPUS CORPORATION
    • 10.2.14. TERUMO

LIST OF TABLES

  • TABLE 1 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 2 MAJOR COMPLICATIONS CAUSED BY GUIDEWIRES DURING ENDOVASCULAR OR STENTING PROCEDURES
  • TABLE 3 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 4 ASIA PACIFIC CORONARY GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 5 ASIA PACIFIC PERIPHERAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 6 ASIA PACIFIC UROLOGICAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 7 ASIA PACIFIC NEUROVASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • TABLE 8 ASIA PACIFIC COATED MARKET 2019-2027 ($ MILLION)
  • TABLE 9 ASIA PACIFIC NON-COATED MARKET 2019-2027 ($ MILLION)
  • TABLE 10 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 11 ASIA PACIFIC HOSPITALS MARKET 2019-2027 ($ MILLION)
  • TABLE 12 ASIA PACIFIC AMBULATORY SURGICAL CENTERS MARKET 2019-2027 ($ MILLION)
  • TABLE 13 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 14 JAPAN VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 15 JAPAN VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 16 JAPAN VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 17 CHINA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 18 CHINA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 19 CHINA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 20 INDIA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 21 INDIA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 22 INDIA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 23 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 24 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 25 AUSTRALIA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
  • TABLE 26 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
  • TABLE 27 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
  • TABLE 28 SOUTH KOREA VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
  • FIGURE 3 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY CORONARY GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 4 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY PERIPHERAL GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 5 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY UROLOGICAL GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 6 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY NEUROVASCULAR GUIDEWIRES 2019-2027 ($ MILLION)
  • FIGURE 7 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET SHARE BY COATING TYPE 2018 & 2027 (%)
  • FIGURE 8 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY COATED 2019-2027 ($ MILLION)
  • FIGURE 9 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY NON-COATED 2019-2027 ($ MILLION)
  • FIGURE 10 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET SHARE BY END USER 2018 & 2027 (%)
  • FIGURE 11 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY HOSPITALS 2019-2027 ($ MILLION)
  • FIGURE 12 ASIA PACIFIC VASCULAR GUIDEWIRES MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
  • FIGURE 13 PORTER'S FIVE FORCE MODEL
  • FIGURE 14 JAPAN VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 15 POPULATION ABOVE 65 YEARS IN JAPAN 2015 & 2050 (%)
  • FIGURE 16 CHINA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 17 INDIA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 18 POPULATION ABOVE 60 YEARS OF AGE 2015 & 2050 (%)
  • FIGURE 19 AUSTRALIA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 20 SOUTH KOREA VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 21 REST OF APAC VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
  • FIGURE 22 VASCULAR GUIDEWIRES COMPANY SHARE ANALYSIS 2018 (%)
Back to Top